Stay updated on Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page.

Latest updates to the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoChange DetectedThe page has removed the phrase 'Last Update Posted (Estimated)' and replaced it with 'Last Update Posted'.SummaryDifference0.0%
- Check23 days agoChange DetectedThe webpage has been updated to reflect new trial information, including the addition of new identifiers and collaborators, as well as a revised last update date. Notably, the previous detailed description of the trial's methodology and participant criteria has been removed.SummaryDifference27%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe page has been updated to reflect the latest version as v2.14.3, replacing the previous version v2.14.2. The estimated last update posted has been removed.SummaryDifference0.1%
- Check45 days agoChange DetectedThe page has been updated to reflect the inclusion of Seagen as a subsidiary of Pfizer, along with new dates related to upcoming events. The previous mention of the Medical Monitor has been removed.SummaryDifference1%
Stay in the know with updates to Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page.